-Search query
-Search result
Showing 1 - 50 of 59 items for (author: burrell & a)

EMDB-47034: 
Pseudosymmetric protein nanocages: GI4-F7 nanocage
Method: single particle / : Park YJ, Dowling QM, Seattle Structural Genomics Center for Infectious Disease (SSGCID), King NP, Veesler D

EMDB-47037: 
Pseudosymmetric protein nanocage GI9-F7
Method: single particle / : Park YJ, Dowling QM, Seattle Structural Genomics Center for Infectious Disease (SSGCID), King NP, Veesler D

EMDB-47039: 
Pseudosymmetric protein nanocage GI16-F7
Method: single particle / : Park YJ, Dowling QM, Seattle Structural Genomics Center for Infectious Disease (SSGCID), King NP, Veesler D

EMDB-47036: 
Pseudosymmetric protein nanocage GI4 -F7 (local refinement)
Method: single particle / : Park YJ, Dowling QM, Seattle Structural Genomics Center for Infectious Disease (SSGCID), King NP, Veesler D

EMDB-47038: 
Pseudosymmetric protein nanocage GI9-F7 (local refinement)
Method: single particle / : Park YJ, Dowling QM, King NP, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D

PDB-9dnd: 
Pseudosymmetric protein nanocage GI4 -F7 (local refinement)
Method: single particle / : Park YJ, Dowling QM, Seattle Structural Genomics Center for Infectious Disease (SSGCID), King NP, Veesler D

PDB-9dne: 
Pseudosymmetric protein nanocage GI9-F7 (local refinement)
Method: single particle / : Park YJ, Dowling QM, King NP, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D

EMDB-41986: 
Human retinal variant phosphomimetic IMPDH1(595)-S477D free octamer bound by GTP, ATP, IMP, and NAD+
Method: single particle / : Calise SJ, Kollman JM

EMDB-41989: 
Human retinal variant phosphomimetic IMPDH1(546)-S477D filament bound by GTP, ATP, IMP, and NAD+, octamer-centered
Method: single particle / : Calise SJ, Kollman JM

EMDB-42012: 
Human retinal variant phosphomimetic IMPDH1(546)-S477D filament bound by GTP, ATP, IMP, and NAD+, interface-centered
Method: single particle / : Calise SJ, Kollman JM

EMDB-42026: 
Human retinal variant phosphomimetic IMPDH1(546)-S477D filament bound by ATP, IMP, and NAD+, octamer-centered
Method: single particle / : Calise SJ, Kollman JM

EMDB-42029: 
Human retinal variant phosphomimetic IMPDH1(546)-S477D filament bound by ATP, IMP, and NAD+, interface-centered
Method: single particle / : Calise SJ, Kollman JM

PDB-8u7m: 
Human retinal variant phosphomimetic IMPDH1(595)-S477D free octamer bound by GTP, ATP, IMP, and NAD+
Method: single particle / : Calise SJ, Kollman JM

PDB-8u7q: 
Human retinal variant phosphomimetic IMPDH1(546)-S477D filament bound by GTP, ATP, IMP, and NAD+, octamer-centered
Method: single particle / : Calise SJ, Kollman JM

PDB-8u7v: 
Human retinal variant phosphomimetic IMPDH1(546)-S477D filament bound by GTP, ATP, IMP, and NAD+, interface-centered
Method: single particle / : Calise SJ, Kollman JM

PDB-8u8o: 
Human retinal variant phosphomimetic IMPDH1(546)-S477D filament bound by ATP, IMP, and NAD+, octamer-centered
Method: single particle / : Calise SJ, Kollman JM

PDB-8u8y: 
Human retinal variant phosphomimetic IMPDH1(546)-S477D filament bound by ATP, IMP, and NAD+, interface-centered
Method: single particle / : Calise SJ, Kollman JM

EMDB-29357: 
Human IMPDH2 mutant - L245P, treated with ATP, IMP, and NAD+; filament assembly interface reconstruction
Method: single particle / : O'Neill AG, Kollman JM

EMDB-29482: 
Human IMPDH2 mutant - L245P, treated with GTP, ATP, IMP, and NAD+; filament assembly interface reconstruction
Method: single particle / : O'Neill AG, Kollman JM

EMDB-29848: 
Human IMPDH2 mutant - L245P, treated with ATP, IMP, and NAD+; extended filament segment reconstruction
Method: single particle / : O'Neill AG, Kollman JM

EMDB-29863: 
Human IMPDH2 mutant - L245P, treated with GTP, ATP, IMP, and NAD+; compressed filament segment reconstruction
Method: single particle / : O'Neill AG, Kollman JM

EMDB-29870: 
Human IMPDH2 mutant - L245P, treated with GTP, ATP, IMP, and NAD+; bent filament segment reconstruction
Method: single particle / : O'Neill AG, Kollman JM

PDB-8foz: 
Human IMPDH2 mutant - L245P, treated with ATP, IMP, and NAD+; filament assembly interface reconstruction
Method: single particle / : O'Neill AG, Kollman JM

PDB-8fuz: 
Human IMPDH2 mutant - L245P, treated with GTP, ATP, IMP, and NAD+; filament assembly interface reconstruction
Method: single particle / : O'Neill AG, Kollman JM

PDB-8g8f: 
Human IMPDH2 mutant - L245P, treated with ATP, IMP, and NAD+; extended filament segment reconstruction
Method: single particle / : O'Neill AG, Kollman JM

PDB-8g9b: 
Human IMPDH2 mutant - L245P, treated with GTP, ATP, IMP, and NAD+; compressed filament segment reconstruction
Method: single particle / : O'Neill AG, Kollman JM

EMDB-24437: 
HUMAN IMPDH1 TREATED WITH ATP, IMP, AND NAD+
Method: single particle / : Burrell AL, Kollman JM

EMDB-24438: 
HUMAN IMPDH1 TREATED WITH ATP, IMP, AND NAD+; OCTAMER-CENTERED
Method: single particle / : Burrell AL, Kollman JM

EMDB-24439: 
HUMAN IMPDH1 TREATED WITH GTP, IMP, AND NAD+; INTERFACE-CENTERED
Method: single particle / : Burrell AL, Kollman JM

EMDB-24440: 
HUMAN RETINAL VARIANT IMPDH1(595) TREATED WITH ATP; INTERFACE-CENTERED
Method: single particle / : Burrell AL, Kollman JM

EMDB-24441: 
HUMAN IMPDH1 TREATED WITH GTP, IMP, AND NAD+ OCTAMER-CENTERED
Method: single particle / : Burrell AL, Kollman JM

EMDB-24442: 
HUMAN RETINAL VARIANT IMPDH1(595) TREATED WITH ATP, OCTAMER-CENTERED
Method: single particle / : Burrell AL, Kollman JM

EMDB-24443: 
HUMAN RETINAL VARIANT IMPDH1(595) TREATED WITH GTP, ATP, IMP, NAD+, INTERFACE-CENTERED
Method: single particle / : Burrell AL, Kollman JM

EMDB-24448: 
HUMAN RETINAL VARIANT IMPDH1(595) TREATED WITH GTP, ATP, IMP, NAD+, OCTAMER-CENTERED
Method: single particle / : Burrell AL, Kollman JM

EMDB-24450: 
HUMAN RETINAL VARIANT IMPDH1(546) TREATED WITH GTP, ATP, IMP, NAD+; INTERFACE-CENTERED
Method: single particle / : Burrell AL, Kollman JM

EMDB-24451: 
HUMAN RETINAL VARIANT IMPDH1(546) TREATED WITH ATP, IMP, NAD+, INTERFACE-CENTERED
Method: single particle / : Burrell AL, Kollman JM

EMDB-24452: 
HUMAN RETINAL VARIANT IMPDH1(546) TREATED WITH ATP, IMP, NAD+, OCTAMER-CENTERED
Method: single particle / : Burrell AL, Kollman JM

EMDB-24454: 
HUMAN RETINAL VARIANT IMPDH1(546) TREATED WITH GTP, ATP, IMP, NAD+; INTERFACE-CENTERED
Method: single particle / : Burrell AL, Kollman JM

PDB-7rer: 
HUMAN IMPDH1 TREATED WITH ATP, IMP, AND NAD+
Method: single particle / : Burrell AL, Kollman JM

PDB-7res: 
HUMAN IMPDH1 TREATED WITH ATP, IMP, AND NAD+, OCTAMER-CENTERED
Method: single particle / : Burrell AL, Kollman JM

PDB-7rfe: 
HUMAN IMPDH1 TREATED WITH GTP, IMP, AND NAD+; INTERFACE-CENTERED
Method: single particle / : Burrell AL, Kollman JM

PDB-7rff: 
HUMAN RETINAL VARIANT IMPDH1(595) TREATED WITH ATP; INTERFACE-CENTERED
Method: single particle / : Burrell AL, Kollman JM

PDB-7rfg: 
HUMAN IMPDH1 TREATED WITH GTP, IMP, AND NAD+ OCTAMER-CENTERED
Method: single particle / : Burrell AL, Kollman JM

PDB-7rfh: 
HUMAN RETINAL VARIANT IMPDH1(595) TREATED WITH ATP, OCTAMER-CENTERED
Method: single particle / : Burrell AL, Kollman JM

PDB-7rfi: 
HUMAN RETINAL VARIANT IMPDH1(595) TREATED WITH GTP, ATP, IMP, NAD+, INTERFACE-CENTERED
Method: single particle / : Burrell AL, Kollman JM

PDB-7rgd: 
HUMAN RETINAL VARIANT IMPDH1(595) TREATED WITH GTP, ATP, IMP, NAD+, OCTAMER-CENTERED
Method: single particle / : Burrell AL, Kollman JM

PDB-7rgi: 
HUMAN RETINAL VARIANT IMPDH1(546) TREATED WITH GTP, ATP, IMP, NAD+; INTERFACE-CENTERED
Method: single particle / : Burrell AL, Kollman JM

PDB-7rgl: 
HUMAN RETINAL VARIANT IMPDH1(546) TREATED WITH ATP, IMP, NAD+, INTERFACE-CENTERED
Method: single particle / : Burrell AL, Kollman JM

PDB-7rgm: 
HUMAN RETINAL VARIANT IMPDH1(546) TREATED WITH ATP, IMP, NAD+, OCTAMER-CENTERED
Method: single particle / : Burrell AL, Kollman JM

PDB-7rgq: 
HUMAN RETINAL VARIANT IMPDH1(546) TREATED WITH GTP, ATP, IMP, NAD+; INTERFACE-CENTERED
Method: single particle / : Burrell AL, Kollman JM
Pages:
Movie
Controller
Structure viewers
About EMN search



wwPDB to switch to version 3 of the EMDB data model
